The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 25, 2019
Filed:
Oct. 21, 2014
Applicant:
Merck Patent Gmbh, Darmstadt, DE;
Inventors:
Hui Qiu, Acton, MA (US);
Richard D. Caldwell, Melrose, MA (US);
Constantin Neagu, Belmont, MA (US);
Igor Mochalkin, San Diego, CA (US);
Lesley Liu-Bujalski, Bedford, MA (US);
Reinaldo Jones, Lowell, MA (US);
Devon Tate, Bedford, MA (US);
Theresa L. Johnson, Salem, MA (US);
Anna Gardberg, Arlington, MA (US);
Assignee:
Merck Patent GmbH, Darmstadt, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07F 5/02 (2006.01); C07D 213/82 (2006.01); C07D 401/04 (2006.01); C07D 409/04 (2006.01); C07D 405/04 (2006.01); C07D 413/14 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 403/04 (2006.01); C07D 405/14 (2006.01); C07D 495/04 (2006.01); C07D 239/47 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 487/04 (2006.01); C07D 239/48 (2006.01); C07D 471/08 (2006.01); C07D 451/02 (2006.01); C07D 213/81 (2006.01); C07D 407/04 (2006.01); C07D 413/04 (2006.01); C07D 413/06 (2006.01); A61K 9/00 (2006.01); A61K 47/06 (2006.01); A61K 47/18 (2017.01); A61K 9/02 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
C07D 401/04 (2013.01); A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 9/0048 (2013.01); A61K 9/0078 (2013.01); A61K 9/02 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/1688 (2013.01); A61K 9/19 (2013.01); A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61K 9/286 (2013.01); A61K 9/2826 (2013.01); A61K 47/06 (2013.01); A61K 47/186 (2013.01); C07D 213/81 (2013.01); C07D 213/82 (2013.01); C07D 239/47 (2013.01); C07D 239/48 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 407/04 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 413/06 (2013.01); C07D 413/14 (2013.01); C07D 451/02 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 495/04 (2013.01); C07F 5/022 (2013.01);
Abstract
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.